X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biopharmadive.com/news/bristol-myers-fda-approval-heart-drug-camzyos-myokardia/622732/
https://www.globenewswire.com/news-release/2022/04/21/2426196/0/en/Evelo-Biosciences-Appoints-John-Maraganore-Ph-D-and-Tassos-Gianakakos-as-Strategic-Advisors.html#:~:text=(Nasdaq%3AEVLO)%2C%20a,joined%20Evelo%20as%20strategic%20advisors.
https://endpts.com/with-delayed-review-date-looming-bristol-myers-uncorks-more-winning-data-for-blockbuster-potential-heart-drug/
https://endpts.com/fda-delays-its-decision-on-bristol-myers-13b-heart-drug-another-three-months/
https://endpts.com/a-couple-months-ahead-of-its-pdufa-data-bristol-myers-rolls-out-long-term-data-for-mavacamten/
https://www.fiercebiotech.com/biotech/bristol-myers-13b-myokardia-heart-drug-gets-along-beta-blockers-as-clock-ticks-down-to-fda
https://www.fiercebiotech.com/biotech/lianbio-snags-325m-ipo-slightly-bigger-than-multi-partnered-biotech-s-2020-series-a
https://www.fiercebiotech.com/biotech/after-bristol-buyout-myokardia-s-clinical-ops-lead-jumps-ship-to-esker-therapeutics
https://www.prweb.com/releases/explorer_hcm_trial_finds_substantial_health_status_improvements_with_mavacamten_in_patients_with_symptomatic_obstructive_hypertrophic_cardiomyopathy_ohcm/prweb17947731.htm
https://endpts.com/fda-accepts-bristol-myers-pitch-for-former-myokardia-drug-clovis-rubraca-aces-advanced-ovarian-cancer-study/
Market Place
Share 
